Lab closures 2019

We offer seven-business-day turnaround for all tests, and a three-business-day rush turnaround option for most tests, except microbiology testing. Our lab is only closed on the following statutory holidays.

Good Friday
Friday, April 19
Easter Monday
Monday, April 22
Victoria Day
Monday, May 20
Canada Day
Monday July 1
B.C. Day
Monday August 5
Labour Day
Monday September 2
Thanksgiving Day
Monday October 14
Remembrance Day
Monday November 11
Christmas Day
Wednesday December 25
Boxing Day
Thursday, December 26
  • Turnaround times explained

    Standard turnaround is 7 business days

    Rush turnaround is 3 business days, except for microbiology, which can’t be rushed

    Even if microbiology is required, a rush option is still available for all other tests

    Microbiology tests start on the first Monday, Wednesday or Friday after receiving your samples

    Samples have to arrive before 3pm PST on a business day

    Once we received your samples, we’ll confirm by email when you can expect your results

  • How to submit a sample

    New clients
    Please contact us. We need to register you as a client before you can submit any samples.

    Registered clients

    1 – Download the relevant Chain of Custody (COC) Form

    COC – Flower and oil

    COC – Edibles and topicals

    COC – Concentrates

    2 – Email your completed form to for review.

    3 – Once your COC has been approved, send it together with your samples to:

    Anandia, Testing Division
    125-887 Great Northern Way
    Vancouver, BC, V5T 4T5

    4 – You will receive an email confirmation that your package has been received, which will include the date your results can be expected.

  • Required sample amounts

    Package testing: 60 g (flower) or 60 mL (oil)

    Potency: 10g (flower) or 5mL (oil)

    Cannabinoid profiling: 10g (flower) or 5mL (oil)

    Heavy metal or total metal: 3g (flower) or 1mL (oil)

    Aflatoxin analysis: 3g (flower) or 1mL (oil)

    Ochratoxin analysis: 3g (flower) or 1mL (oil)

    Loss on drying: 3g (flower)

    Terpene profiling: 10g (flower) or 1mL (oil)

    Residual solvents: 1mL (oil)

    Pesticide analysis (96 Analytes): 3g (flower) or 2mL (oil)

    Microbiology (all required tests): 40g (flower) or 40mL (oil)

    TAMC: 10g (flower) or 10mL (oil)

    TYMC: 10g (flower) or 10mL (oil)

    BTGN: 1g (flower) or 1mL (oil)

    E. coli: 1g (flower) or 1mL (oil)

    Salmonella: 25g (flower) or 25mL (oil)

    S. aureus: 1g (flower) or 1mL (oil)

    P. aeruginosa: 1g (flower) or 1mL (oil)

Canada’s Cannabis Legalization is Helping Expand the Market

NEW YORKJune 25, 2018 /PRNewswire/


According to a research report provided by Marijuana Business Daily, cannabis retail sales continue to grow year-over-year, as new markets emerge, and more states legalize medical and recreational cannabis. Sales in 2018 are expected to surge by approximately 50% when compared to last year, meaning sales value is on track to reach USD 8 Billion – USD10 Billion by the end of this year. The research also estimates that by 2022, annual retail cannabis sales in the United States could top USD 20 Billion, a 200% increase from 2017. As for the economic impact that the new growing industry is set to have, the data predicts an estimated USD 28 Billion – USD 34 Billion economic impact in 2018. GreenTec Holdings Ltd. (TSX-V: GTEC), Aurora Cannabis Inc. (OTCQX: ACBFF), Auxly Cannabis Group Inc. (OTCQB: CBWTF), Supreme Cannabis Company Inc. (OTC: SPRWF), Namaste Technologies Inc. (OTCQB: NXTTF).

Legalization movements are currently succeeding in changing policies beyond the U.S. region. Canada has passed a nationwide legalization of recreational cannabis usage on June 19th, 2018, the second nation to do so after Uruguay. As for the U.S., the process of cannabis legalization for the majority of the West Coast states has already begun, while almost all states have medical use legalized to an extent. And while California is the largest market, Canada is projected to show strong sales as well; Deloitte’s report projects the Canadian market will be worth at least USD 5 Billion in sales in 2018.

GreenTec Holdings Ltd. (TSX-V: GTEC) is listed on the TSX Venture Exchange under the ticker (“GTEC”). Just earlier today, the company announced breaking news that it, “is pleased to provide an update on the operations of its wholly owned subsidiaries. On June 19, 2018 the Canadian Senate passed a bill that will legalize recreational cannabis nationally. Canada is only the second country in the world – and the first G7 nation – to legalize recreational cannabis. The following day, Prime Minister Justin Trudeau announced that Canadians will be able to legally consume cannabis recreationally commencing October 17, 2018. These timelines dovetail very well with the development of GreenTec’s cultivation and lab facilities:

  • Alberta Craft Cannabis Inc. (“ACC”) is a Licensed Producer located in Edmonton, Alberta. ACC operates a 14,000 square foot craft cannabis cultivation facility with estimated annual output of 1.3 million grams. ACC is currently cultivating two different strains of cannabis, to facilitate securing its Sales License from Health Canada’s Office of Medical Cannabis at the earliest opportunity.
  • GreenTec Bio-Pharmaceuticals Inc. (“GreenTec”) is a late stage ACMPR applicant based in Kelowna, British Columbia. GreenTec is currently building a 20,000 square foot craft cannabis cultivation facility with projected annual output of 2.2 million grams. GreenTec has completed design, engineering, permitting and pre-construction work. This facility is expected to be complete by September 2018.
  • Grey Bruce Farms Inc. (“Grey Bruce”) is a late stage ACMPR applicant based in Kincardine, Ontario. Grey Bruce is currently building a 15,000 square foot craft cannabis cultivation facility with projected annual output of 1.6 million grams. Grey Bruce has made substantial progress in completing a major retrofit of its existing industrial building. The company anticipates that this process will be completed by August 2018.
  • Spectre Labs Inc. (“Spectre”) is a cannabis oil extraction facility based in Kelowna, British Columbia. Spectre has acquired land and building to develop the facility, completed initial design work and submitted an application to the Office of Controlled Substances for a Dealer’s License. The site will be developed in a phased approach and will serve as a Good Manufacturing Practices (“GMP”) grade facility with extraction, formulation, compounding and export capabilities to support GTEC’s Licensed Producers and the global medical market. GTEC also intends to utilize Spectre to manufacture edible products that are expected to be incorporated into Health Canada’s regulatory framework in 2019. Upon Health Canada approval of phase one, the facility will be able to produce up to 24,500 grams of cannabis oil per day (equivalent to more than 8,500 kilograms per annum), with capabilities to increase production capacity in future phase development.
  • Tumbleweed Farms Corp. (“Tumbleweed”) is a late stage ACMPR applicant based in Chase, British Columbia. Tumbleweed is currently building a 10,000 square foot craft cannabis cultivation facility with projected annual output of 1.0 million grams. The exterior of this building is almost complete, and substantial progress has been made with respect to interior elements of the facility. Tumbleweed anticipates completing this facility in August 2018. Tumbleweed has also signed a contract with the Pacific Agricultural Certification Society (“PACS”) with a view to becoming one of the first certified organic cannabis companies in Canada.
  • Zenalytic Laboratories Ltd. (“Zen Labs”) is a full-service chemical and microbiological diagnostics laboratory that is in the process of obtaining a Section 56 Class Exemption Dealer’s License under the Narcotic Control Regulations. Zen Labs has received notification from Health Canada’s Office of Controlled Substances (Controlled Drugs Section), that its security compliance inspection is scheduled for June 26, 2018. Upon satisfying the security requirements of the Office of Controlled Substances, Zen Labs expects a follow up inspection on implementation of its instruments, SOP’s, record keeping and analytical processes before being granted its final License. Once Zen Labs receives its Dealers License, GTEC will be able to conduct in-house analytical testing without the risk of delays associated with outsourcing.

Norton Singhavon, Chairman & CEO of GTEC Holdings, provided the following comments: “We are very excited about recent developments facilitating legalization of recreational cannabis on October 17th. We anticipate that we will have significant cultivation capacity in place by this date. Accordingly, we are confident that we are well positioned to become one of the leading vertically integrated craft cannabis companies in Canada“.”

Aurora Cannabis Inc. (OTCQX: ACBFF) is a licensed producer of medical cannabis pursuant to Health Canada’s Access to Cannabis for Medical Purposes Regulations. Aurora Cannabis Inc. and Anandia Laboratories Inc. recently announced that they have signed a binding term sheet whereby Aurora intends to acquire all of the issued and outstanding common shares of privately-held Anandia in an all share transaction valued at approximately USD 115 Million on a fully diluted basis. Anandia’s intellectual property includes the exclusive rights to a number of key genes in the cannabinoid pathway, as well as patents pending for genetic markers. The strength of Anandia’s expert staff, proprietary assets and know-how will provide Aurora with a very significant advantage in developing new cannabis cultivars. For instance, genome-based variety development and technological fortification can tailor metabolite (cannabinoid and terpene) profiles, improve disease resistance, enhance crop yield and optimize flowering time, and can be employed to develop specialized cultivars for oil production. Combining with Aurora gives Anandia access to significant new market opportunities in Canada and internationally through Aurora’s global footprint, according to the Company. “The Transaction will greatly boost our competitive advantage in developing marketable intellectual property and high-margin products and help address diversified needs on a global basis,” concluded Neil Belot, Chief Global Business Development Officer for Aurora.

Auxly Cannabis Group Inc. (OTCQB: CBWTF) is a collective of entrepreneurs with a passion for the cannabis industry past, present and future. The Company recently announced that further to its previously announced transaction on February 16, 2018, the Company has entered into a definitive joint venture agreement with Peter Quiring, one of Canada’s largest greenhouse builders and operators, to develop, construct and operate a fully-automated, state-of-the-art, purpose-built greenhouse for cannabis cultivation in Leamington, OntarioHugo Alves, President of Auxly, stated, “The combination of being the largest builder of greenhouses in Canada and the experience of operating 175 acres of greenhouses in Canada and the United States, truly places Peter in a league of his own. As a cornerstone partnership in the Auxly platform, JVco is a unique opportunity to achieve large-scale, low cost production of cannabis with one of North America’s premier greenhouse operators. Upon completion, this upstream project will be a significant source of product into our midstream value-add and downstream distribution channels. We look forward to building a state-of-the art facility with Peter and his team and a long and successful business partnership.”

Supreme Cannabis Company Inc. (OTC: SPRWF) is a Canadian publicly traded company committed to becoming a leading cultivator and distributor of sun grown cannabis through its wholly-owned subsidiary 7ACRES. 7ACRES is a federally licensed producer of medical cannabis pursuant to the ACMPR operating inside a 342,000 sq. ft. Hybrid Facility. The Company recently announced that it has entered into a definitive agreement pursuant to which Supreme Cannabis will complete a CAD 10,000,000 strategic equity investment in Medigrow. Upon completion of the Investment, Supreme Cannabis will hold an approximate 10% ownership interest in Medigrow. Supreme Cannabis expects strong demand to exceed supply for medical cannabis oil globally and believes Lesotho is well suited to produce quality cannabis oil, while Medigrow possesses the expertise to meet the highest quality standards. Concurrent with the completion of the Investment, Supreme Cannabis and Medigrow have agreed to enter into a long-term global distribution partnership for medical cannabis oil.

Namaste Technologies Inc. (OTCQB: NXTTF) is a global leader in the sale of medical cannabis consumption devices. The Company recently announced that, further to its January 18th, 2018 letter of intent, that the Company has signed a subscription agreement to acquire 10% of the issued share capital of Israeli licensed producer of medical cannabis, Cannbit Ltd for NIS 2,500,000 or approximately CAD 908,000, which includes a combination of both cash and shares. Subsequently, Cannbit has also signed a binding agreement to complete a merger with a company listed on the Tel Aviv stock exchange, whereby Cannbit will retain 85% ownership of the combined public entity. The Company believes that its investment will be immediately accretive in nature based on the valuation metrics of the transaction which consequently valued Cannbit significantly higher than what Namaste acquired its 10% equity stake for. In anticipation of closing this transaction, Namaste has established a supply arrangement with Cannbit to export cannabis to the Canadian market and will also engage with Cannbit to expand the Company’s Israeli-based vaporizer sales platform.

Subscribe Now! Watch us report LIVE
Follow us on Twitter for real time Financial News Updates:
Follow and talk to us on Instagram:
Facebook Like Us to receive live feeds:

About, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on (the ‘Site’) is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. receives fees for producing and presenting high quality and sophisticated content on along with other financial news PR media services. does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For GreenTec Holdings Ltd. financial news dissemination and PR services, has been compensated five thousand dollars by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. will always disclose any compensation in securities or cash payments for financial news PR advertising. does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit:

Media Contact:



Emerald Badges

The Emerald Test™ is an Inter-Laboratory Comparison and Proficiency Test (ILC/PT) program for cannabis testing labs. Proficiency test samples are manufactured by an ISO 17043 accredited PT provider. Results are submitted through an electronic data portal and data analysis is provided by the sample manufacturer with software designed to meet the requirements of ISO 13528:2015.

Every path to success is tested

Please confirm your age and province.

The results are in

In , you must be at least years old to proceed.

This website uses cookies to enable essential features, please review our Cookie Policy for more information on how to manage and personalize your experience.